Last reviewed · How we verify

NCT03519607

The Impact of a Self-help Coping App on Distress Levels in Men Experiencing Infertility

Status unknown NA Last updated 9 May 2018
What this trial tests

NA trial testing FertiStrong App in Stress Reduction in 100 participants. Status unknown.

Timeline
30 April 2018
Primary endpoint
30 June 2018
31 December 2018

Quick facts

Lead sponsorFertility Centers of Illinois
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designfactorial
Maskingsingle
Primary purposesupportive care
Enrollment100
Start date30 April 2018
Primary completion30 June 2018
Estimated completion31 December 2018
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Fertility Centers of Illinois

Who can join

Adults 18 to 55, male only, with Stress Reduction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine if the use of a new app, FertiStrong, is associated with decreased levels of anxiety and depression in men who have infertility or whose partner has infertility.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The Impact of the FertiStrong Mobile Application on Anxiety and Depression in Men: A Randomised Control Pilot Study.
    Domar AD, Jasulaitis L, Matevossian K, Jasulaitis S, et al · · 2023 · cited 4× · PMID 38045496 · DOI 10.4103/jhrs.jhrs_75_23

Verify or expand the search:

Other recruiting trials for Stress Reduction

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03519607.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing